Who is sponsoring NCT03655275?

NCT03655275 is sponsored by Abdelrahman Soliman Alateyh.

What drugs are being tested in NCT03655275?

Interventions in NCT03655275: PRP prolotherapy, Saline prolotherapy.

What condition does NCT03655275 study?

NCT03655275 studies Temporomandibular Joint Disorders.

Is NCT03655275 still recruiting?

NCT03655275 is currently status unknown. Last updated 4 September 2018.

Last reviewed 2018-09-04 · How we verify

NCT03655275

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Effects of Platelet-rich Plasma Prolotherapy of Temporomandibular Joint Subluxation

Status unknown EARLY_PHASE1 Last updated 4 September 2018

What this trial tests

EARLY_PHASE1 trial testing PRP prolotherapy in Temporomandibular Joint Disorders in 22 participants. Status unknown.

Timeline

24 August 2018

Primary endpoint
30 September 2018

30 May 2019

Quick facts

Lead sponsor	Abdelrahman Soliman Alateyh
Phase	EARLY_PHASE1
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	treatment
Enrollment	22
Start date	24 August 2018
Primary completion	30 September 2018
Estimated completion	30 May 2019
Sites	1 location across Egypt

Drugs / interventions tested

PRP prolotherapy — full drug profile →
Saline prolotherapy — full drug profile →

Conditions studied

Temporomandibular Joint Disorders — all drugs for Temporomandibular Joint Disorders →

Sponsor

Abdelrahman Soliman Alateyh — full company profile →

Who can join

Adults 18 to 70, any sex, with Temporomandibular Joint Disorders. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this study is to clinically assess the efficacy of PRP prolotherapy for treatment of TMJ subluxation

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Therapeutic Agents for the Treatment of Temporomandibular Joint Disorders: Progress and Perspective.
Wu M, Cai J, Yu Y, Hu S, et al · · 2020 · cited 28× · PMID 33584275 · DOI 10.3389/fphar.2020.596099

Verify or expand the search:

Other recruiting trials for Temporomandibular Joint Disorders

Currently open trials in the same condition.

NCT07317570 — The Effect of Body Awareness Therapy on Pain, Function and Psychosocial Parameters in Temporomandibular Joint Disorders · NA · recruiting
NCT06763419 — Internal Photobiomodulation For Management Of Temporomandibular Joint Internal Derangement · NA · recruiting
NCT06721104 — Balance, TMJ, Social Adaptive Assessment in Individuals With Autism Spectrum Disorder · recruiting
NCT06500390 — Temporomandibular Disorder in Use of Levonorgestrel Intrauterine System · NA · recruiting
NCT06813040 — Efficacy of Repetitive Transcranial Magnetic Stimulation in Temporomandibular Disorders. · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03655275 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Abdelrahman Soliman Alateyh
Last refreshed: 4 September 2018

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03655275.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing